Global Scientist Day Awards
Frank R. Albano
Commonwealth Serum Laboratories, Australia
| Frank R. Albano |
| Affiliation |
Commonwealth Serum Laboratories |
| Country |
Australia |
| Scopus ID |
56439241400 |
| Documents |
9 |
| Citations |
93 |
| h-index |
4 |
| Subject Area |
Vaccines |
| Event |
Global Scientist Day Awards |
Frank R. Albano is a vaccine-focused researcher and clinical development professional whose published work includes studies of influenza vaccine immunogenicity, safety, reactogenicity, and manufacturing processes. Publicly indexed literature associates him with CSL Seqirus and related clinical-development activities in Australia. His documented publications provide a research record spanning pediatric and adult influenza vaccine studies and earlier immunological research. [2][3]
Abstract
Frank R. Albano is associated with vaccine research and clinical development, with a documented publication record addressing influenza vaccine immunogenicity, safety, reactogenicity, and manufacturing considerations. His research has included pediatric and adult populations and collaborative clinical studies involving quadrivalent influenza vaccines. Publicly indexed articles identify affiliations with CSL Seqirus and related clinical-development activities in Australia.
Keywords
Frank R. Albano; vaccine research; influenza vaccines; clinical development; immunogenicity; vaccine safety; reactogenicity; CSL Seqirus; clinical trials; vaccinology; pharmaceutical research; Australia.[1]
Introduction
Vaccine research requires coordinated investigation of immunogenicity, safety, tolerability, manufacturing, and clinical performance. Frank R. Albano appears as a co-author in several peer-reviewed vaccine studies, particularly involving quadrivalent influenza vaccines. These publications place his work within translational clinical research connecting vaccine development with evidence generated from defined patient populations. [2] [3]
Research Profile
The supplied bibliometric profile identifies nine documents, ninety-five citations, and an h-index of four under Scopus author identifier 56439241400. His indexed literature is principally connected with vaccines and clinical development. PubMed records additionally identify Frank R. Albano as a contributor to influenza vaccine investigations conducted through collaborative research teams. [1] [2]
Research Contributions
Albano’s documented contributions include collaborative investigations of quadrivalent influenza vaccines in children, examination of manufacturing-process effects on vaccine pyrogenicity, and studies evaluating immunogenicity and safety. Earlier work also addressed immune responses during malaria infection, demonstrating a broader historical connection with immunology and host-response research. [2]
Publications
Representative indexed publications include a 2017 phase 3 study comparing quadrivalent inactivated influenza vaccines in children, a 2019 study examining manufacturing-process modification and pyrogenicity in young children, and a 2019 phase 3 investigation of quadrivalent influenza vaccine immunogenicity and safety. A later 2026 publication examined higher-dose cell-based adjuvanted quadrivalent influenza vaccines. [2]
Research Impact
The supplied Scopus indicators provide a measurable description of Albano’s indexed research visibility, while individual publications document contributions to clinical evidence concerning influenza vaccine performance and safety. His papers have appeared in established biomedical journals, including Vaccine and Blood, and address questions relevant to immunization, vaccine formulation, clinical evaluation, and immune responses. [1] [2]
Award Suitability
For an academic recognition framework, the documented record provides several assessable elements, including peer-reviewed publications, indexed research output, citation activity, and sustained participation in vaccine-related clinical research. These materials can be considered alongside eligibility requirements, nomination documentation, research quality, collaboration, and other criteria established by the Global Scientist Day Awards. [1]
Conclusion
Frank R. Albano’s publicly indexed research record reflects participation in vaccine and immunological research, particularly clinical studies of influenza vaccines. The available bibliometric information and peer-reviewed publications provide a factual basis for documenting his research profile. Any formal award determination should be made according to the published eligibility and assessment procedures of the Global Scientist Day Awards. [1]
External Links